Harvard Bioscience Inc reports results for the quarter ended in December - Earnings Summary

Harvard Bioscience

09/03/2023 14:32

* Harvard Bioscience Inc  HBIO.OQ  reported quarterly
adjusted
earnings of 4 cents​​ per share for the quarter ended in
December. The mean expectation of three analysts for the quarter
was for earnings of 3 cents per share.
    * Revenue fell 14% to $28.43 million from a year ago;
analysts
expected $30.33 million. 
    * Harvard Bioscience Inc's reported EPS for the quarter was
a loss
of 4 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Harvard Bioscience Inc shares had fallen by 10.5% this
quarter.
    * The company reported a quarterly loss of $1.67 million.
    * Wall Street's median 12-month price target for Harvard
Bioscience Inc is $3.70 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 9 at 02:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.03           0.04           Beat
 Sep. 30 2022      0.07           -0.01          Missed
 Jun. 30 2022      0.06           0.05           Missed
 Mar. 31 2022      0.05           0.04           Missed